Biora Therapeutics Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Adi Mohanty
Chief executive officer
US$3.1m
Total compensation
| CEO salary percentage | 18.3% |
| CEO tenure | 3yrs |
| CEO ownership | 0.6% |
| Management average tenure | 2.6yrs |
| Board average tenure | 3.4yrs |
Recent management updates
Recent updates
CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$36m |
| Jun 30 2024 | n/a | n/a | -US$87m |
| Mar 31 2024 | n/a | n/a | -US$111m |
| Dec 31 2023 | US$3m | US$574k | -US$124m |
| Sep 30 2023 | n/a | n/a | -US$122m |
| Jun 30 2023 | n/a | n/a | -US$64m |
| Mar 31 2023 | n/a | n/a | -US$52m |
| Dec 31 2022 | US$4m | US$550k | -US$49m |
| Sep 30 2022 | n/a | n/a | -US$118m |
| Jun 30 2022 | n/a | n/a | -US$140m |
| Mar 31 2022 | n/a | n/a | -US$176m |
| Dec 31 2021 | US$10m | US$63k | -US$179m |
Compensation vs Market: Adi's total compensation ($USD3.14M) is above average for companies of similar size in the German market ($USD471.55K).
Compensation vs Earnings: Adi's compensation has been consistent with company performance over the past year.
CEO
Adi Mohanty (57 yo)
3yrs
Tenure
US$3,139,017
Compensation
Mr. Aditya P. Mohanty, also known as Adi,M.B.A. serves as Chief Executive Officer and Director at Biora Therapeutics, Inc. (formerly known as Progenity, Inc.) since November 8, 2021. Mr. Mohanty founded En...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3yrs | US$3.14m | 0.63% € 36.9k | |
| Chief Financial Officer | 5.5yrs | US$1.60m | 0.23% € 13.8k | |
| Senior VP | 10.2yrs | US$1.53m | 0.21% € 12.5k | |
| Head of Human Resources | no data | no data | no data | |
| Senior VP of Strategic Operations | no data | no data | no data | |
| Head of Research | 2.6yrs | no data | no data | |
| Head of Technical Operations | 2.6yrs | no data | no data | |
| Chief Medical Officer | 1.5yrs | no data | no data | |
| Head of Business Development | less than a year | no data | no data |
2.6yrs
Average Tenure
58.5yo
Average Age
Experienced Management: 4ZU's management team is considered experienced (2.6 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO & Director | 3yrs | US$3.14m | 0.63% € 36.9k | |
| Independent Director | 5.4yrs | US$185.11k | 0.050% € 2.9k | |
| Member of Clinical Advisory Board SIBO & Functional Bowel Disorders | no data | no data | no data | |
| Member of Clinical Advisory Board SIBO & Functional Bowel Disorders | no data | no data | no data | |
| Member of Inflammatory Bowel Disease Clinical Advisory Board | 3.4yrs | no data | no data | |
| Chairman of Inflammatory Bowel Disease Clinical Advisory Board | 3.4yrs | no data | no data | |
| Independent Chairman | 5.8yrs | US$208.11k | 0.052% € 3.0k | |
| Member of Clinical Advisory Board - SIBO & Functional Bowel Disorders | no data | no data | no data | |
| Independent Director | 5.8yrs | US$163.11k | 0.049% € 2.9k | |
| Member of Inflammatory Bowel Disease Clinical Advisory Board | 3.4yrs | no data | no data | |
| Independent Director | 3yrs | US$180.11k | 0.049% € 2.9k | |
| Chair of Clinical Advisory Board-SIBO/Functional Bowel Disorders | no data | no data | no data |
3.4yrs
Average Tenure
57yo
Average Age
Experienced Board: 4ZU's board of directors are considered experienced (3.4 years average tenure).